Medically reviewed by Lauren Schlanger, MD Key Takeaways A blood clot in your arm is often associated with a health condition like cancer or the use of an inserted device like a catheter or pacemaker, ...
Deep vein thrombosis (DVT) is a blood clot that forms inside a vein deep in the body, whereas superficial thrombophlebitis (STP) is inflammation of the veins just below the skin’s surface. STP can ...
The first clinical use of heparin was for chemoprophylaxis in surgical patients. In 1937, Murray and Crafoord published data evaluating surgical patients who received prophylaxis for DVT. 14 Despite ...
Deep vein thrombosis, or DVT, is a disorder that kills an estimated 60,000 to 10,000 Americans each year. Dr. Steven Abramowitz, chairman of vascular surgery for MedStar Health, told WTOP that until ...
Twelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and distal deep vein thrombosis (DVT), according to late breaking research ...
An acute pulmonary embolism occurs when a blood clot blocks one or more vessels in the lung. In patients at moderate or high ...
A DVT diagnosis alongside cancer significantly increases health risks, necessitating immediate medical intervention to prevent potentially fatal complications like pulmonary embolism or stroke.
NBA star Victor Wembanyama's recent diagnosis of deep vein thrombosis (DVT) has brought attention to this serious condition. DVT occurs when a blood clot forms in a deep vein, typically in the legs, ...
A new national benchmark in pediatric venous thromboembolism (VTE) care Being designated as the first pediatric NBCA ...
Basilic vein thrombosis is a type of superficial venous thrombosis (SVT) in which a blood clot forms in the basilic vein in the arm. In many cases, SVT is harmless and will resolve without treatment.
The disadvantages of dabigatran include a higher cost compared with warfarin, the need for twice-daily dosing, and a slightly increased risk for gastrointestinal bleeding (6.1% with dabigatran vs 4% ...